T. Murray

1.2k total citations · 1 hit paper
21 papers, 913 citations indexed

About

T. Murray is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, T. Murray has authored 21 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in T. Murray's work include Radiopharmaceutical Chemistry and Applications (6 papers), Medical Imaging Techniques and Applications (4 papers) and Medical Imaging and Pathology Studies (3 papers). T. Murray is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Medical Imaging Techniques and Applications (4 papers) and Medical Imaging and Pathology Studies (3 papers). T. Murray collaborates with scholars based in United Kingdom, United States and Australia. T. Murray's co-authors include T. E. Hilditch, Alison H. Thomson, J Cassidy, S S Burtles, Daniela Fraier, Peter D. Wilson, Stan B. Kaye, Rachel Morrison, Ruth Duncan and Lilian S. Murray and has published in prestigious journals such as Cancer Research, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

T. Murray

20 papers receiving 888 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.

1999 574 citations P. Vasey, Stan B. Kaye et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. Murray United Kingdom	10	360	338	209	177	106	21	913
Christian Ché Canada	6	444 1.2×	650 1.9×	213 1.0×	177 1.0×	40 0.4×	11	1.1k
Jean‐Paul Castaigne United States	13	492 1.4×	849 2.5×	230 1.1×	298 1.7×	57 0.5×	28	1.7k
Igor Skidan United States	9	588 1.6×	510 1.5×	293 1.4×	173 1.0×	57 0.5×	10	1.2k
Elijus Undzys Canada	17	438 1.2×	263 0.8×	398 1.9×	206 1.2×	50 0.5×	23	839
Ann‐Marie Chacko United States	18	256 0.7×	299 0.9×	221 1.1×	173 1.0×	44 0.4×	47	1.0k
Rameshwar Patil United States	20	567 1.6×	493 1.5×	433 2.1×	134 0.8×	70 0.7×	35	1.2k
Maggie Kozman United States	6	235 0.7×	420 1.2×	167 0.8×	99 0.6×	28 0.3×	6	775
Jenolyn F. Alexander United States	16	330 0.9×	279 0.8×	370 1.8×	96 0.5×	34 0.3×	22	972
Bin Sheng Wong United States	12	217 0.6×	306 0.9×	415 2.0×	113 0.6×	79 0.7×	13	945
Federica Piccardi Italy	15	278 0.8×	654 1.9×	309 1.5×	220 1.2×	36 0.3×	22	1.5k

Countries citing papers authored by T. Murray

Since Specialization

Citations

This map shows the geographic impact of T. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Murray more than expected).

Fields of papers citing papers by T. Murray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Murray. The network helps show where T. Murray may publish in the future.

Co-authorship network of co-authors of T. Murray

This figure shows the co-authorship network connecting the top 25 collaborators of T. Murray. A scholar is included among the top collaborators of T. Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Murray. T. Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Quaranta, Valeria, Carolyn Rainer, Sebastian R. Nielsen, et al.. (2018). Macrophage-Derived Granulin Drives Resistance to Immune Checkpoint Inhibition in Metastatic Pancreatic Cancer. Cancer Research. 78(15). 4253–4269. 115 indexed citations

Holben, David H., et al.. (2010). A Multi-Disciplinary Lifestyle Intervention Program Decreases Cardiovascular Disease Risk in Adults after 100 Days of Treatment. Journal of the American Dietetic Association. 110(9). A89–A89. 1 indexed citations

Davidson, Melanie, David D’Souza, James C. Yuen, et al.. (2007). Does Intraoperative Ultrasound Guidance Benefit Routine Intracavitary Cervical Carcinoma Brachytherapy?. International Journal of Radiation Oncology*Biology*Physics. 69(3). S403–S404. 2 indexed citations

Conway, Robert M., et al.. (2005). Retinoblastoma: Animal Models. Ophthalmology Clinics of North America. 18(1). 25–39. 10 indexed citations

McDonagh, J. E. R., et al.. (2004). Thyroid and stomach uptake in 99mTc-MAA lung perfusion scans. Nuclear Medicine Communications. 25(4). 423–424. 1 indexed citations

Murray, T.. (2003). Wait Not, Want Not: Factors Contributing to the Development of Anorexia Nervosa and Bulimia Nervosa. The Family Journal. 11(3). 276–280. 12 indexed citations

Murray, T., et al.. (2000). Technetium-99m-tetrofosmin: retention of nitrogen atmosphere in kit vial as a cause of poor quality material. Nuclear Medicine Communications. 21(9). 845–849. 1 indexed citations

Murray, T., et al.. (2000). 99Tcm-MAG3: Problems with radiochemical purity testing. Nuclear Medicine Communications. 21(1). 71–75. 6 indexed citations

Vasey, P., Stan B. Kaye, Rachel Morrison, et al.. (1999). Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.. PubMed. 5(1). 83–94. 574 indexed citations breakdown →

10.

Murray, T. & Joseph F. Siebenaller. (1993). Differential Susceptibility of Guanine Nucleotide-binding Proteins to Pertussis Toxin-catalyzed ADP-ribosylation in Brain Membranes of Two Congeneric Marine Fishes. Biological Bulletin. 185(3). 346–354. 12 indexed citations

11.

Williams, John A., et al.. (1992). The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: Evidence for the protective effect of chlormethiazole. Neuropharmacology. 31(4). 315–321. 68 indexed citations

12.

Owens, Janel E., T. Murray, James McCulloch, & D. Wyper. (1992). Synthesis of (R, R)¹²³I‐QNB, A spect imaging agent for cerebral muscarinic acetylcholine receptors in vivo. Journal of Labelled Compounds and Radiopharmaceuticals. 31(1). 45–60. 16 indexed citations

13.

Willmott, N., T. Murray, Yang Chen, et al.. (1991). Development of radiolabelled albumin microspheres: a comparison of gamma-emitting radioisotopes of iodine (131I) and indium (111In/113mIn). International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(7). 687–694. 2 indexed citations

14.

Murray, T., et al.. (1991). The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour. British Journal of Cancer. 63(2). 308–310. 25 indexed citations

15.

Hilditch, T. E., et al.. (1990). Fifteen Years of Radiological Protection Experience in a Regional Radiopharmacy. Health Physics. 59(1). 109–116. 5 indexed citations

16.

Murray, T., et al.. (1990). Investigation of factors affecting ashesion of 99Tcm labelled colloids to glass vials. Nuclear Medicine Communications. 11(5). 375–382. 8 indexed citations

17.

Sanders, Rebecca & T. Murray. (1988). Chronic theophylline exposure increases agonist and antagonist binding to A1 adenosine receptors in rat brain. Neuropharmacology. 27(7). 757–760. 19 indexed citations

18.

Murray, T., et al.. (1988). Automated radiopharmaceutical dispensing. Nuclear Medicine Communications. 9(5). 363–367. 1 indexed citations

19.

Murray, T., et al.. (1986). Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.. PubMed. 27(7). 1150–3. 29 indexed citations

20.

Hilditch, T. E., et al.. (1986). Formation of large particles in a 99Tcm-tin colloid preparation. Nuclear Medicine Communications. 7(11). 845–850. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact